Table 6 .
Other intraoperative and postoperative variables monitored
| Placebo group (n=100) | Tranexamic acid group (n=100) | P | |
|---|---|---|---|
| Volume of crystalloids infused intraoperatively (mL) | 3660 (1140) | 3658 (1180) | 0.9 |
| Volume of colloids infused intraoperatively (mL) | 350 (366.6) | 286 (340.2) | 0.2 |
| Topical haemostatic drug use during surgery* | 44 (44) | 37 (37) | 0.3 |
| Surgery length (min) | 166 (44) | 159 (40) | 0.3 |
| Time spent in recovery room (min) | 58 (34) | 50 (25) | 0.074 |
| Volume of crystalloids infused during postoperative stay in hospital (mL) | 4773 (2282) | 4640 (2461) | 0.7 |
| Length of postoperative hospitalisation (days) | 9 (4.3) | 9 (4.3) | 0.9 |
| Fluid drain loss, 0-48 h postoperatively (mL) | 412 (244.3) | 361 (366.0) | 0.2 |
All data are mean (standard deviation) unless stated otherwise.
*Data are number of patients (%).